ReviewFrontiers in pharmacology2014

Relaxin-3/RXFP3 networks: an emerging target for the treatment of depression and other neuropsychiatric diseases?

Craig M Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.